PROVIDER PROFILE · NPI 1639250327

Frank LinnM.D.

GastroenterologyConcord, MAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

465

Unique beneficiaries

—

Total services

538

Distinct HCPCS

Medicare payment

$59K

Peer benchmark

Total Medicare services vs. 483 Gastroenterology providers in MA — below median (cohort median 638).

PRESCRIBING · PART D · 2024

Total Rx claims

389

Beneficiaries

—

Total drug cost

$27K

Distinct drugs

Brand share

11.1%

Top prescribed drugs

Omeprazole79 claims

Famotidine70 claims

Ondansetron Hcl65 claims

Pantoprazole Sodium60 claims

Sod Sulf/Pot Chloride/Mag Sulf23 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$2K

Payment records

101

By payment type

Food and Beverage$2K

Education$54

REFERRAL NETWORK

Where Frank Linn's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 8 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
David Sherman Pathology · Concord, MA	55	126
David Rose Diagnostic Radiology · Boston, MA	27	64
INTRIERE, LISA	25	50
Dan Nir Diagnostic Radiology · Providence, RI	15	33
Quest Diagnostics Massachusetts Llc Clinical Laboratory · Marlborough, MA	14	45
Anjum Butte Cardiology · Boston, MA	13	37
Thomas Lamattina Cardiology · Concord, MA	11	24
Iris Bonilla-Yoon Diagnostic Radiology · Boston, MA	11	17

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history